Analyst Ratings for Menlo Therapeutics (MNLO)

MNLO Rating Summary

  |   Expand Research on MNLO
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/21/2020 Northland Capital Markets
» Updated 6/1/2020
Tim Chiang New Coverage Outperform
(N/A)
6.00
(3.50)
1.97
(1.35)
-31.47% Details
3/25/2020 Barclays
» Updated 5/13/2020
Balaji Prasad New Coverage Overweight
(N/A)
3.00
(2.00)
3.13
(1.35)
-56.87% Details
Like MNLO Ratings? Also take a look at BIOD, SRRA, KALV, ACRS

MNLO Ratings News